Studies on transcription termination and splicing of the rRNA precursor in vivo in the presence of proflavine.
In isolated nucleoli from Tetrahymena thermophila, low concentrations of the intercalating agent proflavine inhibit both transcription termination and splicing of the rRNA precursor. Proflavine also exerts an in vivo effect on the process of transcription termination under conditions, where the growth rate is only slightly reduced. Thus, approximately 40% of the rRNA precursor molecules, accumulated in nucleoli during 60 min of treatment with the drug, are longer than the normal 35S rRNA precursor. R-Loop mapping of these longer precursor molecules isolated after 30 and 60 min of incubation demonstrates that the RNA polymerases have a 50 fold lower elongation rate in the spacer region than in the coding region. Proflavine in the given concentration is found to have no significant effect on the splicing of properly terminated precursor molecules. In contrast, none of the longer non-terminated molecules are found to be spliced. These results indicate that proflavine primarily affects the process of transcription termination and that the splicing event is inhibited due to the improper termination of the precursor molecule.
D000166:Acridines / Q000494:pharmacology*; D000818:Animals; D002466:Cell Nucleolus / Q000187:drug effects / Q000378:metabolism*; D004247:DNA / Q000235:genetics*; D004275:DNA, Ribosomal; D005796:Genes / Q000187:drug effects*; D008854:Microscopy, Electron; D009690:Nucleic Acid Conformation; D009693:Nucleic Acid Hybridization; D011370:Proflavine / Q000494:pharmacology*; D012335:RNA, Ribosomal / Q000235:genetics*; D013768:Tetrahymena / Q000378:metabolism*; D014158:Transcription, Genetic / Q000187:drug effects*
D000166:Acridines; D004275:DNA, Ribosomal; D012335:RNA, Ribosomal; D004247:DNA; D011370:Proflavine